Viral Vector Market Growth Driven by Expanding Gene Therapy Applications
The global viral vector market size was estimated at USD 4.25 billion in 2025 and is projected to reach USD 10.22 billion by 2033, growing at a CAGR of 11.69% from 2026 to 2033. The increasing prevalence of target diseases and genetic disorders, along with technological advancements in digital diagnostics, is expected to support the market growth for viral vectors. Rising investments in gene therapy research, increasing development of personalized medicine, and growing demand for advanced biologic therapies are also contributing significantly to the expansion of the viral vector market worldwide. Viral vectors are widely used in gene therapy, vaccine development, and cell-based therapies to deliver genetic material into target cells. These vectors play a critical role in the treatment of genetic disorders, cancer, infectious diseases, and rare diseases by enabling efficient gene transfer and therapeutic modification. Advancements in biotechnology, increasing clinical trial acti...